SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is facing significant downward pressure following its latest financial update, where despite reporting solid top-line revenue growth and a surprise quarterly profit, the company lowered its full-year guidance due to weaker-than-expected transaction volumes in Germany and currency headwinds. The community is actively debating whether this sell-off is an overreaction by the market or a justified response to mounting valuation and execution risks, with many traders looking for potential entry points as the stock attempts to find support.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending as investors weigh an upcoming earnings report against significant short interest and recent analyst coverage that set a high price target. While community sentiment remains polarized between bulls tracking AI infrastructure contracts and bears voicing concerns over dilution and financing, traders are closely monitoring potential volatility ahead of the expected earnings release.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as the bond market grapples with rising long-term Treasury yields, driven by concerns over persistent inflation, ballooning national debt, and ongoing geopolitical instability in the Strait of Hormuz. Community discussion is heavily divided between those betting on a recession-driven flight to safety and investors warning that structural fiscal issues and high issuance may push bond prices significantly lower.

Amylyx Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of therapies for diseases with significant unmet medical need, with an emphasis on endocrine and neurodegenerative disorders. Its program, avexitide, is a once-daily GLP-1 receptor antagonist being developed for the treatment of post-bariatric hypoglycemia. Amylyx’s pipeline also includes investigational programs targeting Wolfram syndrome and amyotrophic lateral sclerosis (ALS). The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.

Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals is gaining strong community attention and trading momentum driven by positive Phase 3 clinical trial results for its avexitide treatment, fueling discussions around its commercial potential and potential buyout interest. Investors are actively debating the company's valuation, upcoming pipeline catalysts, and the impact of reduced short interest on the stock's price discovery.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is facing intense market volatility as investors react to mixed quarterly earnings and ongoing speculation surrounding a potential IPO for its AI chip subsidiary, Kunlunxin. Community discussion remains polarized, with some traders viewing current price levels as a deep-value opportunity tied to long-term AI and cloud growth, while skeptics emphasize concerns over sluggish legacy search revenue and broader regulatory risks surrounding Chinese tech.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble is trending as institutional investors and community members react to its pivot into a high-growth AI infrastructure player, fueled by a record-breaking revenue guidance and strategic data center acquisitions. The stock is currently seeing intense community focus on a potential short squeeze, driven by significant short interest and anticipation that upcoming cloud compute contracts will rapidly scale the company's valuation.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is trending following a quarterly earnings report that exceeded analyst expectations, providing a moderate boost to investor sentiment despite the company maintaining its full-year guidance. The community is actively debating the impact of the challenging housing market, with many focused on whether resilient demand for smaller projects can continue to offset broader economic headwinds.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as traders speculate on a potential short squeeze, fueled by growing institutional accumulation and excitement around the company's agentic AI orchestration capabilities. The community is actively debating the stock's transition toward profitability and its long-term potential as a key player in the enterprise software ecosystem.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital is trending as investors aggressively debate the company's shift toward AI infrastructure, with community sentiment deeply polarized between those betting on a potential breakout and shareholders frustrated by sustained poor performance and consistent insider selling. Discussion is dominated by skepticism regarding CEO leadership, persistent financial losses, and comparisons to peers that have more successfully integrated AI into their business models.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending as investors weigh its pivot toward becoming an AI infrastructure provider against potential regulatory and geopolitical headwinds. The community is actively debating the company's competitive position as Chinese AI models gain global adoption, with sentiment divided between bullish outlooks on AI-driven growth and concerns over the stock's long-term performance as a value trap.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (Amylyx or the Company) today announced positive topline results from LUCIDITY, a 78-participant, multicenter, randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating the efficacy and safety of avexitide, an investigational...

Why Is AMLX Stock Popping 14% After Hours?

Equity

Amylyx said the company said it will release top-line results from its late-stage trial of blood sugar drug avexitide on Tuesday.

Amylyx Pharmaceuticals Stock Soars After the Close: Here's Why

Amylyx Pharmaceuticals shares are trading higher Monday after the company scheduled a Phase 3 trial results readout for this week.read more...

Amylyx Pharmaceuticals to Announce Topline Results from its Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia on August 18, 2026

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (Amylyx or the Company) will announce topline results from its Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia on August 18, 2026. Amylyxs senior management team will host a conference call and audio webcast at 8:00 a.m. ET. To...

4 Biotech Stocks With Major Second-Half Pipeline Catalysts This Year

Vertex Pharmaceuticals, Amylyx Pharmaceuticals, Praxis Precision Medicines and BridgeBio Pharma face major 2026 catalysts, from FDA decisions to late-stage readouts.

Is Editas Medicine (EDIT) Outperforming Other Medical Stocks This Year?

Here is how Editas Medicine (EDIT) and Amylyx Pharmaceuticals, Inc. (AMLX) have performed compared to their sector so far this year.

Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (Amylyx or the Company) today reported financial and business results for the second quarter ended June 30, 2026. With the last participants final study visit recently completed, we are eagerly anticipating the expected topline data readout of the pivotal...

Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (Amylyx or the Company) will report its second quarter 2026 financial results on Thursday, August 6, 2026. Amylyxs senior management team will host a conference call and audio webcast at 8:00 a.m. ET to discuss the financial results and other company...

Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, July 3, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at...

Is Amylyx Pharmaceuticals, Inc. (AMLX) Stock Ready for a Breakout Ahead of Key LUCIDITY Trial Data?

Is Amylyx Pharmaceuticals, Inc. (AMLX) Stock Ready for a Breakout Ahead of Key LUCIDITY Trial Data...

https://files.quartr.com/streams/2026-08-18/8599e53a-6733-4254-ad29-68540ca4d44f/1/live_transcript.jsonl?ref=U3RvY2t0d2l0cw==

Study result

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

Investors are celebrating positive Phase 3 topline results showing avexitide significantly reduced dangerous hypoglycemic events.

Bullish sentiment builds as analysts upgrade targets toward $30 and beyond, fueled by de-risked clinical trial outcomes.

The stock is experiencing a dramatic recovery, rallying from lows to become a primary focus in the biotech sector.

Feed

News

Sentiment

Earnings

Fundamentals

Info

AMLXAmylyx Pharmaceuticals Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest AMLX News